ProPhase Labs, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $40.6M | $-2.9M | $-3.6M | $-7.8M | $405.0K | $-1.1M | $-2.7M | $-3.5M |
| Depreciation & Amortization | $337.0K | $426.0K | $367.0K | $277.0K | $243.0K | $252.0K | $355.0K | $363.0K |
| Depreciation | $337.0K | $426.0K | $367.0K | $277.0K | $243.0K | $252.0K | $355.0K | $363.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $78.0K | $1.0K | $135.0K | $1.0M | $269.0K | $246.0K | $131.0K | $192.0K |
| Net Cash from Operating Activities | $-2.8M | $-472.0K | $-3.5M | $-3.2M | $1.1M | $-5.7M | $-2.1M | $-3.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $208.0K | $651.0K | $718.0K | $312.0K | $442.0K | $310.0K | $300.0K | $153.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $21.8M | $-651.0K | $-709.0K | $-306.0K | $-442.0K | $-310.0K | $-134.0K | $-1.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $16.3M | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-16.2M | $-100.0K | $2.9M | $4.8M | $371.0K | $1.1M | $-449.0K | $133.0K |
| Net Change in Cash | $2.7M | $-1.2M | $-1.3M | $1.3M | $1.1M | $-5.0M | $-2.7M | $-4.6M |
| Free Cash Flow | $-3.0M | $-1.1M | $-4.2M | $-3.5M | $695.0K | $-6.0M | $-2.4M | $-3.7M |